Cargando…
POT1 loss-of-function variants predispose to familial melanoma
Deleterious germline variants in CDKN2A account for around 40% of familial melanoma cases(1), while rare variants in CDK4, BRCA2, BAP1, and the promoter of TERT, have also been linked to the disease(2-5). Here we set out to identify novel high-penetrance susceptibility genes in unexplained cases by...
Autores principales: | Robles-Espinoza, Carla Daniela, Harland, Mark, Ramsay, Andrew J., Aoude, Lauren G., Quesada, Víctor, Ding, Zhihao, Pooley, Karen A., Pritchard, Antonia L., Tiffen, Jessamy C., Petljak, Mia, Palmer, Jane M., Symmons, Judith, Johansson, Peter, Stark, Mitchell S., Gartside, Michael G., Snowden, Helen, Montgomery, Grant W., Martin, Nicholas G., Liu, Jimmy Z., Choi, Jiyeon, Makowski, Matthew, Brown, Kevin M., Dunning, Alison M., Keane, Thomas M., López-Otín, Carlos, Gruis, Nelleke A., Hayward, Nicholas K., Bishop, D. Timothy, Newton-Bishop, Julia A., Adams, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266105/ https://www.ncbi.nlm.nih.gov/pubmed/24686849 http://dx.doi.org/10.1038/ng.2947 |
Ejemplares similares
-
Germline TERT promoter mutations are rare in familial melanoma
por: Harland, Mark, et al.
Publicado: (2015) -
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
por: Yokoyama, Satoru, et al.
Publicado: (2011) -
Management of Melanoma Families
por: Bergman, Wilma, et al.
Publicado: (2010) -
Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
por: Emran, Abdullah Al, et al.
Publicado: (2020) -
Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
por: Gallagher, Stuart J, et al.
Publicado: (2015)